- Serum Chemerin Levels in relation to Osteoporosis and Bone Mineral Density: A Case-Control Study
- Renalase levels in children with solitary functioning kidney
- Thyroid-stimulating hormone decreases HMG-CoA reductase phosphorylation via AMP-activated protein kinase in the liver
- Ameliorating effects of gypenosides on chronic stress-induced anxiety disorders in mice
- PP.27.05: SIMVASTATIN DOES NOT CHANGE THE HYPERREACTIVITY TO PHENYLEPHRINE IN AORTA FROM ISOPROTERENOL-TREATED MICE.
- Neuropeptide FF Promotes Recovery of Corneal Nerve Injury Associated With Hyperglycemia
- SP321 RENALASE, RENAL FUNCTION AND BIOMARKERS OF ENDOTHELIAL DYSFUNCTION IN CHRONIC KIDNEY DISEASE PATIENTS
- Effects of renal tubular dysfunction on bone in tenofovir-exposed HIV-positive patients
- The combined treatment with novel platinum(II) complex and anti-MUC1 increases apoptotic response in MDA-MB-231 breast cancer cells
- Serum salusin-α and salusin-β levels in patients with psoriasis
- The skin remodeling in type 1 diabetes and insulin resistance animal models.
- Cold exposure stimulates lipid metabolism, induces inflammatory response in the adipose tissue of mice and promotes the osteogenic differentiation of BMMSCs via the p38 MAPK pathway
- Pterostilbene improves glycaemic control in rats fed an obesogenic diet: involvement of skeletal muscle and liver
- Induction of Haemeoxygenase-1 Directly Improves Endothelial Function in Isolated Aortas from Obese Rats through the Ampk-Pi3k/Akt-Enos Pathway
- Serum Levels of Annexin A2 as a Candidate Biomarker for Hepatic Fibrosis in Patients With Chronic Hepatitis B
- Antidiabetic Effect of Galantamine: Novel Effect for a Known Centrally Acting Drug
- Fecal microbiota transplantation and bacterial consortium transplantation have comparable effects on the re-establishment of mucosal barrier function in mice with intestinal dysbiosis
- In vitro method for the screening and monitoring of estrogen-deficiency osteoporosis by targeting peripheral circulating monocytes
- In vivo
- Thrombosis in Hemodialysis Patients; Their Association with Tissue Factor and Tissue Factor Pathway Inhibitor
